NCT06931275Recruiting
Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes
Implementing Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes
Source: ClinicalTrials.gov · Last updated 17 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The overall goal of the study is to create a standardized, stakeholder-informed system within EMRs, that will enable an equitable and regular prescription and documentation of advanced diabetes technologies. This will reduce racial disparities and generate an understanding of the reasons behind prescription decisions. The study will highlight the development and implementation an EMR-based Best Practice Advisory (BPA). The study will answer whether the EMR-based BPA can effectively reduce disparities. Additionally, it will explore why providers may not prescribe advanced diabetes technologies. Patients will also be surveyed to understand their perspectives on developing the EMR-based BPA.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 1178 (estimated)
- First submitted
- 9 Sept 2024
- Start date
- 13 Aug 2024
- Primary completion date
- 30 Jul 2027
- Lead sponsor
- T1D Exchange, United States
- Diseases
- Type 1 diabetes
- NCT number
- NCT06931275
What you commit to
- Study type: Interventional
- Planned participants: 1178
- From 13 Aug 2024 to the primary completion date, 30 Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- PwT1D with evidence of use of AID at baseline
Who the study is looking for
- non-Hispanic Black and Hispanic individuals
Criteria the registry did not label
- Age ≥ 2 years with an EMR diagnosis of T1D for at least 6 months at baseline and receiving care at one of six intervention centers or a matched control at another T1DX-QI center.
Age in the registry: 2 years to 95 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| T1D Exchange Coordinator of this site? Confirm its status | Boston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.